Barchetta et al. examined the relationship between plasma copeptin levels and the presence and severity of MASLD and metabolic dysfunction-associated steatohepatitis (MASH) in 60 individuals with obesity undergoing bariatric surgery. The gene discussed is AVP; the disease is metabolic dysfunction-associated steatotic liver disease.